Table 3.

Survival estimates by AR level for all patients and by tumor type

RFS
No. of relapsesNo.5-y survival95% CI upper95% CI lowerLog-rank P value
OverallAR < -0.085711730.52380.41540.62130.0002
AR ≥ -0.085531740.75640.66470.8263
HER2+AR < -0.08514260.21220.04460.45950.1893
AR ≥ -0.08510170.16740.01190.4866
ER+ and/or PR+AR < -0.08530660.61090.45750.73300.0144
AR ≥ -0.085391410.82660.73290.8899
TNAR < -0.08527810.52860.33430.69010.3422
AR ≥ -0.0854160.74670.39430.9123
OS


No. of Deaths
No.
5-y survival
95% CI upper
95% CI lower
Log-rank P value
OverallAR < -0.085501620.64070.53010.73180.0037
AR ≥ -0.085391620.78590.68860.8559
HER2+AR < -0.08510180.33990.11870.57890.4447
AR ≥ -0.0856140.49230.16270.7586
ER+ and/or PR+AR < -0.08525630.73850.58070.84440.0600
AR ≥ -0.085321320.81760.71580.8857
TN
AR < -0.08515810.72550.56630.83440.1650
AR ≥ -0.0851160.91670.53900.9878